' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | QLS applies quantitative strategies using AI and machine learning to estimate probabilities of success, correlations within and across therapeutic areas, and overall enterprise risk, giving clients a clearer picture of the risk and reward of their portfolios of biomedical assets. |
h1 tags | Your page doesn't have H1 tags. |
h2 tags | News BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020 Informa Pharma Intelligence and QLS Partner to Pilot Predictive Analysis Tool for Clinical Trials Ask a Question |
Site Speed | 0.32184815406799 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| qlsadvisors.com | A | IN | 3600 | |
| qlsadvisors.com | NS | IN | 3600 | ns69.domaincontrol.com |
| qlsadvisors.com | NS | IN | 3600 | ns70.domaincontrol.com |
| qlsadvisors.com | SOA | IN | 3600 | |
| qlsadvisors.com | MX | IN | 3600 | qlsadvisors-com.mail.protection.outlook.com |
| qlsadvisors.com | TXT | IN | 3600 | |
| qlsadvisors.com | TXT | IN | 3600 | |
| qlsadvisors.com | TXT | IN | 3600 |